文献
J-GLOBAL ID:202102224235907874
整理番号:21A0093510
フェーズIb臨床試験における局所進行または転移性胃/胃食道接合部腺癌患者における第一選択治療としてのオキサリプラチン/カペシタビンと併用したシンチリマブの安全性と有効性【JST・京大機械翻訳】
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
著者 (15件):
Jiang Haiping
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Zheng Yulong
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Qian Jiong
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Mao Chenyu
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Xu Xin
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Li Ning
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Xiao Cheng
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Wang Huan
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Teng Lisong
(Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Zhou Hui
(Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China)
,
Wang Shuyan
(Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China)
,
Zhu Donglei
(Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc, Suzhou, China)
,
Peng Bo
(Department of Translational Medicine, Innovent Biologics, Inc, Suzhou, China)
,
Shen Lin
(Department of Medical Oncology, Beijing Cancer Hospital, Beijing, China)
,
Xu Nong
(Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
20
号:
1
ページ:
1-8
発行年:
2020年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)